Literature DB >> 12635059

The effect of high-frequency ventilation of the lungs on postbypass oxygenation: A comparison with other ventilation methods applied during cardiopulmonary bypass.

Deeb Zabeeda1, Revaz Gefen, Beniamin Medalion, Vadim Khazin, Arie Shachner, Tiberiu Ezri.   

Abstract

OBJECTIVE: To compare the effect of high-frequency ventilation versus other ventilation methods applied during cardiopulmonary bypass on postbypass oxygenation.
DESIGN: Prospective, randomized study.
SETTING: University hospital. PARTICIPANTS: Seventy-five patients undergoing coronary artery bypass graft surgery.
INTERVENTIONS: Patients were allocated to 5 equal groups of different ventilation methods during bypass. Groups 1 and 2 received high-frequency, low-volume ventilation with 100% and 21% oxygen, respectively. Groups 3 and 4 received 5 cm H(2)O of continuous positive airway pressure (CPAP) with either 100% or 21% oxygen. Patients from group 5 were disconnected from the ventilator during the bypass period.
MEASUREMENTS AND MAIN RESULTS: Spirometry data, blood gas analysis, oxygen saturation as measured by pulse oximetry, and end-tidal carbon dioxide were recorded 5 minutes before chest opening, 5 minutes before bypass, 5 minutes after bypass, 5 minutes after chest closure and 6, 12, 18, and 24 hours after surgery. There were no differences in compliance and mean airway pressures. Alveolar-to-arterial oxygen gradients increased, and PaO(2) decreased significantly (p < 0.05) in all groups 5 minutes after bypass and this trend continued in the postoperative period. Patients from group 3 had higher PaO(2) and lower alveolar-to-arterial oxygen gradients, 5 minutes after weaning from bypass (p < 0.05). Extubation times were similar in all groups.
CONCLUSIONS: The alveolar-arterial oxygen gradient was lower, and the PaO(2) was higher 5 minutes after bypass in patients receiving CPAP (100% O(2)) as compared with those ventilated with high-frequency ventilation. Copyright 2003, Elsevier Science (USA). All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12635059     DOI: 10.1053/jcan.2003.8

Source DB:  PubMed          Journal:  J Cardiothorac Vasc Anesth        ISSN: 1053-0770            Impact factor:   2.628


  5 in total

1.  Different strategies for mechanical VENTilation during CardioPulmonary Bypass (CPBVENT 2014): study protocol for a randomized controlled trial.

Authors:  Elena Bignami; Marcello Guarnieri; Francesco Saglietti; Enivarco Massimo Maglioni; Sabino Scolletta; Stefano Romagnoli; Stefano De Paulis; Gianluca Paternoster; Cinzia Trumello; Roberta Meroni; Antonio Scognamiglio; Alessandro Maria Budillon; Vincenzo Pota; Alberto Zangrillo; Ottavio Alfieri
Journal:  Trials       Date:  2017-06-07       Impact factor: 2.279

2.  Ventilation during cardiopulmonary bypass for prevention of respiratory insufficiency: A meta-analysis of randomized controlled trials.

Authors:  Dongmei Chi; Chan Chen; Yu Shi; Wanyu Wang; Ye Ma; Ronghua Zhou; Hai Yu; Bin Liu
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

3.  Comparative Study between Different Modes of Ventilation during Cardiopulmonary Bypass and its Effect on Postoperative Pulmonary Dysfunction.

Authors:  Noha Sayed Hussain; Ayman Anis Metry; George Mikhail Nakhla; Rami Mounir Wahba; Milad Zakery Ragaei; John Nader Bestarous
Journal:  Anesth Essays Res       Date:  2019 Apr-Jun

4.  Low tidal volume mechanical ventilation against no ventilation during cardiopulmonary bypass heart surgery (MECANO): study protocol for a randomized controlled trial.

Authors:  Lee S Nguyen; Messaouda Merzoug; Philippe Estagnasie; Alain Brusset; Jean-Dominique Law Koune; Stephane Aubert; Thierry Waldmann; Jean-Michel Grinda; Hadrien Gibert; Pierre Squara
Journal:  Trials       Date:  2017-12-02       Impact factor: 2.279

5.  Ventilation strategies with different inhaled Oxygen conceNTration during CardioPulmonary Bypass in cardiac surgery (VONTCPB): study protocol for a randomized controlled trial.

Authors:  Meng-Qiu Zhang; Yu-Qi Liao; Hong Yu; Xue-Fei Li; Liang Feng; Xiao-Yun Yang; Hai Yu
Journal:  Trials       Date:  2019-05-03       Impact factor: 2.279

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.